The steroid hormone, estradiol, is essential for both the growth of normal breast and induction of mammary carcinomas. The growth promoting eects of estrogen are presumed to be mediated by growth factors, in particular, epidermal growth factor, which mediates its eects through erbB receptors, erbB1 and erbB2/C-neu. C-neu is ampli®ed and over-expressed in a large number of human cancers and transgenic mice over-expressing Cneu also develop mammary tumors. However, as yet, the impact of C-neu over-expression on estrogen action during normal mammary development and hence, its precise role in carcinogenesis, remains unclear. In the present studies, we demonstrate that estradiol-dependent mammary ductal growth accompanying puberty is impaired in transgenic mice expressing wild type Cneu, and is intrinsic to the tissue. The impairment is not due to an overall impairment in estrogen action, since progesterone receptor expression is unaected in C-neu mice. It is also not due to an intrinsic inability of the epithelial cells to proliferate, since impeded ductal growth co-exists with alveolar growth during pregnancy. Therefore, we propose that, depending on the physiological state, C-neu may either promote or inhibit the growth of mammary epithelial cells, and discuss its potential signi®cance to carcinogenesis. Oncogene (2000) 19, 5982 ± 5987.
Introduction
The female sex steroid hormone, estradiol, is essential for the growth and dierentiation of normal breast, induction of mammary carcinomas and growth of some of these carcinomas. According to our current understanding of the mechanism of action of estradiol and progesterone, the eects of these steroids are mediated through their cognate receptors (Tsai and O'Malley, 1994; Mangelsdorf et al., 1995) . The initial phase of mammary development begins at the onset of puberty when the epithelial cells invade the surrounding fatty stroma (referred to as the fat pad) and form a tree-like pattern of ducts which reach the periphery of the fat pad (Daniel and Silberstein, 1987) . For this phase of development, estradiol signaling through estrogen receptor alpha (ERa) is essential, such that in mammary glands of mice lacking ERa, there is a marked impairment in ductal growth (Bocchinfuso and Korach, 1997) . Also, implantation of anti-estrogen pellets into mammary glands of non-ovariectomized mice can retard ductal growth (Silberstein et al., 1994) .
It is generally presumed that while estrogen is essential for triggering mammary growth, its eects are mediated by growth factors which signal through the family of erbB receptors. In support of this, it has been shown that in ovariectomized mice, depleted of endogenous estrogen, implantation of pellets containing epidermal growth factor (EGF) or transforming growth factor alpha (TGF-a) into regressed mammary glands, can initiate ductal growth (Coleman et al., 1988; Snedeker et al., 1991) . Consistent with the ability of EGF and TGF-a in promoting ductal growth, erbB1 and erbB2/C-neu expression has been shown to occur during puberty (Deckard-Janatpour, 1997; Schroeder and Lee, 1998) and this is associated with the end bud structures (Deckard-Janatpour, 1997), which represent the sites of active proliferation (Bresciani, 1968) . It has also been shown that estradiol can activate both erbB1 and erbB2 (Sebastian et al., 1998) .
It is well established that erbB1 and neu are each ampli®ed and over-expressed in approximately 30% of human breast cancers (Slamon et al., 1987; 1989) . Consistent with these clinical observations, in transgenic mice over-expressing C-neu, there is an induction of multifocal mammary tumors (Guy et al., 1992 (Guy et al., , 1996 . Over-expression of C-neu has also been observed in mammary tumor cells maintained in cell culture. In contrast to normal mammary glands, estradiol promotes tumor cell proliferation but down-regulates C-neu expression in ER positive tumor cells (Read et al., 1990; Antoniotti et al., 1992; Russel and Hung, 1992) . Thus, the observations on tumor cells and normal mammary glands, taken together, indicate that the mechanisms governing the interaction between signaling through ER and C-neu are complex. To the extent that over-expression of C-neu is associated with mammary carcinogenesis, these observations also suggest that appropriate signaling through these two receptors may be critical for maintaining cellular replicative homeostasis, which becomes deranged when there is an imbalance in the expression of C-neu. We tested this hypothesis, using as a model, C-neu transgenic mice expressing the wild type form of C-neu. We asked if inappropriate expression of C-neu could aect mammary ductal growth, since this phase of development is dependent on signaling through ER.
Results
Mammary growth in pubertal C-neu mice is impaired and is not due to host-derived factors During puberty, the extension of the ducts to the periphery of the fat pad occurs between 8 ± 10 weeks of age in wild type mice and is referred to as complete ®lling of the fat pad. The extent of fat pad ®lling by the ducts, therefore, serves as a criterion for assessing the intrinsic ability of the mammary epithelial cells to undergo ductal growth. As shown in Figure 1 , in pubertal C-neu mice, both in heterozygotes and homozygotes, there was less ®lling of the fat pad, as compared to wild type mice (compare panel A with panels B and C). Furthermore, as reported in earlier studies , the ducts in the glands of C-neu mice had a speculated appearance, characterized by the presence of numerous side buds (compare panel E with panel F); these earlier studies, however, had not discussed the extent of fat pad ®lling in the glands of these mice. Adult heterozygotes (10 ± 18 weeks old), in most cases, had complete fat pad ®lling, similar to wild type mice. In contrast, in several adult (10 ± 18 weeks) homozygotes, there was still an incomplete ®lling of the fat pad (compare panels D and G). The degree of impairment in ductal growth in adult homozygotes varied between individual mice and, overall, was less severe in older mice.
Analyses for serum levels of estradiol did not reveal any signi®cant dierences between wild type and C-neu mice (data not shown). However, it was possible that, independent of estradiol, some other host-derived factors(s) was responsible for impeding mammary ductal growth in C-neu mice. It is well established that mammary epithelial cells will grow when transplanted into de-epithelialized (cleared) fat pads of syngenic hosts (De Ome et al., 1959) . Therefore, to assess whether the impaired ductal growth in mammary glands of C-neu mice was intrinsic to the tissue or due to host derived factors; we transplanted the glands of wild type mice into cleared fat pads of C-neu mice. As shown in Figure 1H , the transplants from wild type mice in C-neu hosts did not exhibit any impairment in ductal growth indicating that the impairment was intrinsic to the tissue of C-neu mice. Table 1 summarizes the data on the relative ability of these various tissues to undergo ductal elongation.
Impairment in mammary ductal growth in C-neu mice is related to the level of C-neu expression in mammary glands
Having found that the reasons for impaired ductal growth in C-neu mice resided at the tissue level, we analysed for ER a gene expression, as described previously (Shyamala et al., 1992) , since ER a is essential for this phase of development (Bocchinfuso and Korach, 1997) . These studies did not reveal any signi®cant dierences between the mammary glands of C-neu and wild type mice (data not shown). Next, we considered the possibility that the impeded ductal growth might be related to increased C-neu expression especially since this phenomenon was more severe in homozygotes as compared to heterozygotes (Table 1 ). The C-neu transgenic mice, used in these studies, express the wild type form of C-neu controlled by the mammary gland speci®c promoter from mouse mammary tumor virus (Guy et al., 1992) . It is well established that the mouse mammary tumor virus (MMTV) promoter contains glucocorticoid/progesterone responsive elements whereby these steroids can modulate MMTV dependent gene expression (Ham et al., 1988) . In particular, in vitro studies have shown that progesterone, signaling through its receptor (PR) can modulate MMTV-dependent gene expression (Vegeto et al., 1993) . Therefore, it seemed plausible that altering the steady-state levels of PR, in vivo, would lead to changes in the activity of the MMTV promoter and hence, in the steady-state levels of MMTV-derived C-neu expression in mammary glands. Our laboratory had previously created transgenic mice carrying additional PR as transgene (Shyamala et al., 1998) . Therefore, to alter the steady-state levels of PR in C-neu mice, we crossed the C-neu mice with the PR mice transgenic and examined the mammary glands of the hybrid mice for C-neu expression and also for their ability to undergo ductal elongation.
Analyses for the steady-state levels of C-neu in mammary glands of various genotypes are shown in Figure 2A . As expected, C-neu expression was higher in mammary glands of C-neu heterozygotes as compared to wild type mice. On the other hand, in mammary glands of hybrid mice (also heterozygous for MMTV-derived C-neu gene), the level of C-neu was dramatically reduced. More importantly, the reduced levels of C-neu expression in the mammary glands of hybrid mice was accompanied by unimpaired ductal Figure 2B ), similar to the glands of both wild type and PR transgenic mice (Table 1) .
Progesterone receptor (PR) expression is not impeded in mammary glands of C-neu mice
The fact that there were no signi®cant dierences between C-neu and wild type mice, either with respect to serum levels of estradiol or mammary expression of ER a indicated that the impaired ductal growth was due to an impairment in estradiol-dependent signaling in mammary glands of these mice. Therefore, to identify whether this was due to an overall impairment or restricted to pathways essential for ductal elongation, we analysed for progesterone receptor (PR) expression; in mammary glands, estradiol augments the expression of PR at the level of both mRNA and protein (Shyamala et al., 1990 (Shyamala et al., , 1992 . Initially, we veri®ed that PR expression was regulated by estradiol in pubertal wild type mice using in situ localization techniques. This was necessary because: (a) expression of PR is hetgerogeneous in the mammary glands of wild type mice (Silberstein et al., 1996; Shyamala et al., 1997) , and thus, biochemical analyses can lead to artifactual results arising from the dilution of PR positive cells by PR negative cells; and (b) using biochemical assays, it had been reported that mammary glands of pubertal mice were not sensitive to estradiol with respect to PR expression (Haslam, 1988; Raafat et al., 1999) . As shown in Figure 3 , we found that mammary glands of ovariectomized pubertal mice had a decreased expression of PR, as compared to intact control mice (compare panel A with B). In ovariectomized mice treated with estradiol, PR expression was similar to that of intact mice (compare panel a with panel C), indicating that PR expression in pubertal mice was indeed dependent on estradiol. Similar to wild type mice, in the mammary glands of both pubertal and adult C-neu mice, PR was detected and overall, the intensity of immunoreactivity was similar to that observed with wild type mice (Figure 4 ; compare panel A with panels B and C, and compare panel D with panels E and F). Similar results were also obtained with Balb/c mice, the strain used in studies by Raafat et al. (1999) (data not shown). The extent of ductal elongation was examined in whole mounts of mammary glands. Growth to the edge of the distal lymph node (present in all mice, prior to puberty) was estimated to be 25%. The data represent mean+s.e.m. and the number of specimens examined (n) is given in parentheses 
Lobulo-alveolar growth is not impeded in mammary glands of C-neu mice
In addition to estradiol, progesterone also promotes the proliferation of mammary epithelial cells and this is mainly associated with alveolar cells (Bresciani, 1968) . Indeed, progesterone signaling through PR is essential for lobulo-alveolar growth accompanying pregnancy (Lydon et al., 1995) . Therefore, having found that PR expression was unimpeded in mammary glands of Cneu mice, we examined their ability to achieve lobuloalveolar growth. As shown in Figure 5 , similar to adult nulliparous mice, mammary glands from several early pregnant (6 days) homozygous C-neu mice had incomplete ®lling of the fat pad (Figure 4 , compare panel A with panel C). On the other hand, despite the impeded ductal development, mammary glands of these mice did exhibit extensive side-branching, a characteristic associated with the beginning of lobulo-alveolar growth, similar to that observed with wild type pregnant mice (compare panel B with panel D).
Discussion
In the present studies, we have demonstrated that overexpression of wild type C-neu impairs mammary ductal growth accompanying puberty, which requires estradiol signaling through ER a. The impeded ductal growth in C-neu mice is not due to diminished levels of serum estradiol or other host-derived factors since tissues from wild type mice transplanted in C-neu hosts do not exhibit any impairment. Also, with a decrease in steady-state levels of C-neu in PR/C-neu hybridization mice, ductal elongation is not inhibited. Since the degree of impairment is more severe in homozygotes, as compared to heterozygotes, these combined observations suggest that it may be related to C-neu expression and/or activity of C-neu in mammary glands. Regardless, the observations from transplantation studies and those using PR/C-neu hybrid mice, taken together, indicate that the biological basis for the impaired mammary ductal elongation in C-neu mice resides at the tissue level, i.e., it is cell autonomous. Our studies also reveal that the impairment in ductal growth in C-neu mice was not due to an overall impairment in the ability of ductal cells to respond to estradiol since PR expression, a well-de®ned marker for estrogen action, is unimpeded in the ducts of these Figure 4 PR expression is not impeded in mammary glands of C-neu mice. Panels on the left show DAPI staining of nuclei which correspond to panels on the right which show FITC staining of PR in the same tissue section. (A ± C) Show mammary glands from pubertal (6-week-old) wild type, heterozygous C-neu and homozygous C-neu mice, respectively. (D ± F) Show mammary glands from adult (12-week-old) wild type, heterozygous C-neu and homozygous C-neu mice, respectively glands. In addition they also demonstrate that mammary glands of pubertal mice can respond to estradiol with an increase in PR expression and these results are in contradiction with previous observations an pubertal mice using biochemical assays (Haslam et al., 1988; Raafat et al., 1999) . This is not due to any strain dierences since this occurs both in FVB and Balb/c mice. Since PR expression is heterogenous in mammary glands, we believe that in previous studies using biochemical assays and tissue extracts, the inability to detect changes in PR expression with estradiol treatment was most likely due to mixing of receptor positive cells with receptor negative cells thus giving rise to artifactual results.
A noteable phenomenon with regard to the action of EGF in mammary glands is that while exogenous EGF promotes ductal growth in mammary glands of ovariectomized mice, (Coleman et al., 1988; Snedeker et al., 1991) , it inhibits ductal morphogenesis in intact pubertal mice (Coleman and Daniel, 1990) . Ovariectomy results in the depletion of endogenous estradiol but does not result in a decrease in the steady-state levels of ER a in mammary glands (Shyamala et al., 1992) . Ovariectomy also does not appear to aect the expression of EGF-receptor (erbB1) and post-receptor intermediates (Coleman et al., 1988) . Thus, it would appear that, as found with C-neu mice, it is not the mere presence of ER a but estradiol-dependent signaling which appears to dictate the actions of both EGF and erbB2 in mammary glands. At present, the mechanisms underlying these opposing eects of EGF on mammary development and their precise relationship to ovarian hormones are not understood. However, EGF-induced inhibition of ductal growth in hormonally intact mice is believed to occur via normal morphogenetic pathways (Coleman and Daniel, 1990) . EGF signals through erbB1, which preferentially dimerizes with erbB2 (Graus-Porta et al., 1997) . Thus, in C-neu mice, due to a greater potential availability of erbB2, an increase in erbB1/erb2 complexes can be expected. If this were so, the activity of the endogenous EGF will be enhanced in mammary glands of C-neu mice which can then account for the impeded ductal growth in these mice, analogous to that seen in intact wild type mice supplemented with exogenous EGF.
An important observation to emerge from our present studies is that the mammary glands of C-neu mice do not exhibit any impairment in lobulo-alveolar growth and in fact, lobulo-alveolar growth can co-exist with impeded ductal development during early pregnancy. In wild type mice, maximal expression and activation of C-neu occurs only during mid-to-late pregnancy (Schroeder and Lee, 1998) , a physiological state associated with alveolar proliferation and declining sensitivity to estrogen (Shyamala, 1987) . Once again, the decline in estrogen sensitivity during pregnancy is not due to diminished levels of ER a (Shyamala and Haslam et al., 1980) . Thus, it is worthwhile to note that in all cases examined so far, during late pregnancy or lactation, there were no apparent dierences in the extent of epithelial growth between the wild type and C-neu mice (data not shown). This suggests that, in normal mammary glands, the eects of erbB2 may be bi-functional and dependent on the physiological state. As such, when mammary cells proliferate in response to estrogendependent signaling during puberty it has a growth inhibitory eect while during physiological states when mammary glands have a diminished ability to respond to estrogen, e.g. with ovariectomy or pregnancy, it has a growth-promoting eect.
In summary, our present studies indicate that the mechanisms governing the interactions between signaling through ER a and C-neu, during mammary gland development, are complex. In particular, they emphasize that appropriate signaling through these two receptors is critical for maintaining cellular replicative homeostasis, which becomes deranged when there is an imbalance in the expression of C-neu. These studies also raise the possibility that the growth-promoting eects of C-neu may only manifest in normal mammary epithelial cells with decreased estrogenic sensitivity. Therefore, it may be that the cells that are targeted for transformation by C-neu predominately represent an estrogen-insensitive population. This, in turn, may account at least partially, for the well known phenomenon that mammary tumors which overexpress C-neu are resistant to endocrine therapy (Slamon et al., 1987 (Slamon et al., , 1989 .
Materials and methods

Transgenic and control mice
The C-neu transgenic mice expressing the wild type C-neu were generated by our laboratory from the parental line (Guy et al., 1992) provided by Dr W Muller. PR-A transgenic mice were created by our laboratory (Shyamala et al., 1998) . All these transgenic mice and control wild type mice were of FVB strain.
Wholemount preparation
The entire number 4 inguinal mammary glands were removed, ®xed in Cornoy's solution (acidic ethynol) at room temperature and processed as described previously (Shyamala et al., 1998) .
Tissue transplantation
Mammary fat pads devoid of epithelium were prepared according to the cleared fat pad technique of De Ome et al. (1959) by using 21-day-old mice. Mammary tissue fragments from donor mice (*1.5 mm 2 ) were implanted within the cleared fat pads and the transplants were examined at de®ned times after transplantation.
Analysis for PR
For examining the immunolocalization of PR, an indirect immuno¯uorescence assay using an antibody prepared against mouse PR was used, as described previously (Shyamala et al., 1997) .
Analyses for C-neu expression
The steady-state levels of C-neu were estimated using previously described procedures (Muthuswamy et al., 1994; Siegel et al., 1999) . In short, tissue samples pulverized in liquid nitrogen and lysed in TNE buer (50 mM Tris pH 8.0, 150 mM NaCl, 2 mM EDTA, 1% Nonidet P-40, 1 mM sodium orthovanadate, 1 mM sodium¯uoride, 10 mg of leupeptin and 10 mg of aprotinin per ml), cleared by centrifuging at 14 000 g for 30 min at 48C. C-neu in the lysates was immunoprecipitated with anti C-neu antibody (AB 3, Oncogene Science) and absorbed with protein Asepharose. The proteins in the immunoprecipitate were subjected to immunoblot analysis, using anti C-neu antibody (Ab-3; Oncogene Science) and the proteins were visualized by an enhanced chemiluminescence system (Amersham).
